000			01842nam a2200289 4500
001			ESSALUD
005			20260902163915.0
007			ta
008			t pe ||||| |||| 00| 0 spa d
040			_aBMG
041			_aeng
100			_aOspel, Johanna M. _954490
245			_aEndovascular therapy for medium-vessel occlusion stroke — Narrowing the target population
300			_apáginas: 1955-1957
520			_aOne way to classify acute ischemic stroke is by the anatomy of vessel occlusion. Initial randomized trials of endovascular thrombectomy focused on large-vessel occlusions. These proximal occlusions of the intracranial carotid artery or the stem of the middle cerebral artery (MCA) represent the most severe form of anterior circulation ischemic stroke. The large clinical benefit from endovascular thrombectomy is consistent with the patent artery hypothesis and reperfusion associated with intravenous thrombolysis. Reperfusion success after endovascular thrombectomy is now routinely achieved in 90% of patients, but early reperfusion, as measured with computed tomographic (CT) angiography at approximately 2 to 4 hours after treatment with intravenous thrombolysis, occurs in only 35 to 40% of patients with large-vessel occlusions and in 50% of those with more-distal medium-vessel occlusions.
650			_aICTUS _954458
650			_aRADIOLOGÍA GENERAL _954381
650			_aNEUMOLOGÍA _925628
650			_aENFERMEDAD ARTERIAL PERIFÉRICA Y AÓRTICA _954459
650			_aNEUROLOGÍA
650			_aGERIATRÍA _91852
650			_aMEDICINA DE URGENCIAS _953820
650			_aCUIDADOS INTENSIVOS _95208
700			_aHill, Michael D. _954491
773	0		_022717 _922669 _dMassachusetts NEJM Group _oNEJM014 _tThe New England Journal of Medicine _wESSALUD _x0028-4793
942			_cARTICULOS _e2026-08-31 _zsqb
999			_c22909 _d22909